Restless legs syndrome is common enough in the general population, affecting roughly 3% of people. But among patients on maintenance hemodialysis, the numbers are startlingly different: systematic reviews put the prevalence somewhere between 15% and 30%. For years, that gap has been chalked up to the usual suspects — iron deficiency, the buildup of uremic toxins, and the cardiovascular strain of kidney failure. A new study in Frontiers in Neurology argues those explanations are incomplete, and that the real pathway runs through the body and the mind before it reaches the legs.
A Five-Year Look at Who Develops RLS
Researchers at the Second Affiliated Hospital of Xingtai Medical College in China followed 321 hemodialysis patients over five years, from August 2020 to August 2025. Rather than measuring symptoms at a single moment, they tracked how each patient's physical and psychological state changed over time, then compared 96 patients who developed restless legs syndrome against 96 matched controls who did not.
That longitudinal design matters. Restless legs syndrome does not appear overnight, and a snapshot cannot reveal which changes precede the disorder and which merely accompany it. By watching trajectories unfold, the team could ask a sharper question: what actually sets a dialysis patient on the path toward RLS?
Two Culprits: Wasting and Depression
Two factors stood out. Sarcopenia — the progressive loss of muscle mass and strength — was associated with a 58% increase in the odds of developing RLS (adjusted odds ratio 1.58). Depression raised the risk incrementally with severity, and crucially, the two fed on each other: patients with both sarcopenia and worsening depression faced a risk greater than either factor alone would predict.
When the researchers modeled how much of the total RLS risk flowed through these evolving conditions, the numbers were substantial. Depression accounted for roughly 44% of the risk pathway, anxiety about 46%, frailty 46%, and sarcopenia 46%. In other words, nearly half of the journey from kidney failure to restless legs appears to be mediated by declining muscle and declining mood — not by the kidney impairment alone.
Following the Chain Down to Dopamine
Association studies can identify travelers on the same road without proving the direction of travel. To probe cause, the team added a second method: Mendelian randomization, which uses genetic variants as natural experiments to test whether one condition genuinely drives another.
The genetic analysis traced a coherent chain. Reduced kidney function (lower eGFR) was causally linked to a higher risk of depression. Depression, in turn, was linked to suppressed metabolism of dopamine 3-O-sulfate — a marker of the dopamine system that has long been central to restless legs syndrome. That depression-to-dopamine step accounted for roughly 41% of the total effect. Notably, anxiety did not hold up as a reliable causal link in this pathway, even though it tracked alongside RLS in the observational data — a useful reminder that correlation and causation can diverge.
The authors describe the result as a "somatopsychic-neurological cascade": kidney failure erodes the body and the mind, and that erosion ultimately reaches the brain's dopamine machinery, where restless legs syndrome takes hold.
Why It Matters Beyond Iron
The practical message is that treating RLS in dialysis patients purely as an iron or cardiorenal problem may miss much of the picture. The study's authors argue that management should "transcend isolated cardiorenal or iron-supplementation parameters" and instead involve early, multi-system screening — actively preserving muscle strength and proactively treating depression, rather than waiting for the neurological symptoms to arrive.
That reframes RLS in this population as potentially preventable further upstream. If muscle wasting and low mood are waypoints on the road to restless legs, then physical rehabilitation and mental health care are not just quality-of-life measures — they may be a way to keep the disorder from developing at all.
Limitations to Keep in Mind
This was a single-center study, and its cohort was modest in size, so the specific numbers should be read as signals rather than settled figures. The Mendelian randomization analysis strengthens the causal argument but rests on genetic data drawn from broad populations, not this particular group of patients. And while the pathway the authors describe is biologically plausible and internally consistent, confirming it will require larger, multi-center work.
What This Means for Patients
If you or someone you care for is on dialysis and struggling with the nightly urge to move the legs, this research suggests the conversation with your care team should be broader than iron levels. Muscle loss and depression are common, under-treated, and — according to this study — may be quietly feeding restless legs syndrome. Both are treatable. Addressing them is worthwhile in its own right, and this work raises the possibility that doing so early could also spare patients one more source of lost sleep.
